Intertech Bio
2007
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
2
FINANCING ROUNDS
Description
Provider of bio-pharmaceutical services. The company's bio-pharmaceutical services focuses on developing products to treat cancer, infectious diseases and other medical conditions associated with compromised immune systems, enabling cancer patients to get cure of malignant tumors and uncontrolled cell division.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Breitling Energy
Primary Office
- 3910 Cypress Creek Parkway
- Suite 100
- Houston, TX 77068
- United States
Intertech Bio Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Intertech Bio‘s full profile, request access.
Request full access to PitchBook